Evaluating new diagnostic markers for complicated appendicitis
New Diagnostic Markers In Dignosis Of Complicated Appendix
This study is testing if certain blood markers can help doctors better identify complications in patients with appendicitis who need surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 10 Years to 40 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06102239 on ClinicalTrials.gov |
What this trial studies
This study investigates the efficacy of hyperbilirubinemia and hyponatremia as diagnostic indicators for complicated appendicitis. Patients admitted for acute appendicitis will undergo surgery, and their bilirubin, sodium, and C-reactive protein levels will be measured post-operatively. The goal is to determine if these markers can help identify complications such as perforation more effectively. The findings could lead to improved diagnostic protocols for acute appendicitis.
Who should consider this trial
Good fit: Ideal candidates are patients admitted for acute appendicitis who will undergo surgical intervention.
Not a fit: Patients with liver disease, pregnancy, or other specified exclusions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of diagnosing complicated appendicitis, potentially reducing the risk of severe complications.
How similar studies have performed: While there is limited information on similar studies, the approach of using biochemical markers for diagnosis has shown promise in other conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patient admitted for acute appendicitis underwent surgery and post operativly confirmed histopathology of acute appendicitis Exclusion Criteria: * patient with liver disease Liver transplantation Chronic alcoholism Congental biliary disease Pregnancy Appendicular neoplasm Hemolytic disease Hepatocellular carcinoma
Where this trial is running
Sohag
- Sohag University hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Amr M Amin, Residents
- Email: amr_mohamed_post@med.sohag.edu.eg
- Phone: 01113486740
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.